Abstract
The use of dilutions differing by small arithmetic increments was studied as a means for improving the definition and measurement of minimum inhibitory concentrations and precision parameters for testing Pseudomonas aeruginosa versus the aminoglycosides by the broth microdilution test. For five strains of P. aeruginosa versus gentamicin, tobramycin, and amikacin, comparisons were made of minimum inhibitory concentrations which were replicated in parallel by using three microdilution systems: small increment panels prepared by us, modified twofold dilution panels prepared by us, and similar modified twofold dilution panels obtained commercially. The small increment dilutions were prepared to differ by concentrations of 1.0 microgram/ml for gentamicin and tobramycin and by 2.0 micrograms/ml for amikacin. Use of the small increment dilutions resulted in the ability to measure minimum inhibitory concentrations at more closely spaced intervals than those dictated by modified twofold dilution schemes, and confidence limits were significantly improved. The average coefficient of variation for the small increment microdilution test results was 9.5%, with 99.5% of minimum inhibitory concentrations falling within +/- 2 small increment dilutions from their modal values.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barry A. L., Thornsberry C., Jones R. N. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories. J Clin Microbiol. 1981 May;13(5):1000–1003. doi: 10.1128/jcm.13.5.1000-1003.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barry A. L., Thornsberry C., Jones R. N., Gerlach E. H. Gentamicin, tobramycin, and sisomicin disc susceptibility tests. Revised zone standards for interpretation. Am J Clin Pathol. 1981 Apr;75(4):524–531. doi: 10.1093/ajcp/75.4.524. [DOI] [PubMed] [Google Scholar]
- Kenny M. A., Pollock H. M., Minshew B. H., Casillas E., Schoenknecht F. D. Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin. Antimicrob Agents Chemother. 1980 Jan;17(1):55–62. doi: 10.1128/aac.17.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krasemann C., Hildenbrand G. Interpretation of agar diffusion tests. J Antimicrob Chemother. 1980 Mar;6(2):181–187. doi: 10.1093/jac/6.2.181. [DOI] [PubMed] [Google Scholar]
- Mangione A., Schentag J. J. Therapeutic monitoring of aminoglycoside antibiotics: an approach. Ther Drug Monit. 1980;2(2):159–167. doi: 10.1097/00007691-198004000-00010. [DOI] [PubMed] [Google Scholar]
- Pollock H. M., Minshew B. H., Kenny M. A., Schoenknecht F. D. Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1978 Sep;14(3):360–367. doi: 10.1128/aac.14.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reller L. B., Schoenknecht F. D., Kenny M. A., Sherris J. C. Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis. 1974 Nov;130(5):454–463. doi: 10.1093/infdis/130.5.454. [DOI] [PubMed] [Google Scholar]
- Sarubbi F. A., Jr, Hull J. H. Amikacin serum concentrations: prediction of levels and dosage guidelines. Ann Intern Med. 1978 Nov;89(5 Pt 1):612–618. doi: 10.7326/0003-4819-89-5-612. [DOI] [PubMed] [Google Scholar]
- Woolfrey B. F., Fox J. M., Quall C. O. An analysis of error rates for disc agar-diffusion testing of Pseudomonas aeruginosa versus aminoglycosides. Am J Clin Pathol. 1981 Apr;75(4):559–564. doi: 10.1093/ajcp/75.4.559. [DOI] [PubMed] [Google Scholar]
- Woolfrey B. F., Fox J. M., Quall C. O. Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa. Am J Clin Pathol. 1981 Jan;75(1):39–44. doi: 10.1093/ajcp/75.1.39. [DOI] [PubMed] [Google Scholar]
- Woolfrey B. F., Ramadei W. A., Quall C. O. Evaluation of the moving intermediate zone concept for determing susceptibility of pseudomonads to gentamicin by the standardized disk agar-diffusion test. Am J Clin Pathol. 1979 Nov;72(5):861–863. doi: 10.1093/ajcp/72.5.861. [DOI] [PubMed] [Google Scholar]
- Woolfrey B. F., Ramadei W. A., Quall C. O. Inability of the standardized disk agar-diffusion test to measure susceptibility of the fluorescent group of pseudomonads to gentamicin. Am J Clin Pathol. 1978 Sep;70(3):337–342. doi: 10.1093/ajcp/70.3.337. [DOI] [PubMed] [Google Scholar]
- Zaske D. E., Cipolle R. J., Strate R. J. Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function. Surgery. 1980 Feb;87(2):164–169. [PubMed] [Google Scholar]